FDA Announces Targeted Sampling, Additional Efforts to Enhance the Safety of Leafy Greens
The U.S. Food and Drug Administration (FDA) is committed to enhancing the safety of leafy greens through continued implementation of the Leafy Greens STEC Action Plan (LGAP). As part of this effort the FDA is announcing targeted sampling of leafy greens grown on farms and ranches during the fall 2022 harvest season in the Salinas Valley region of California, releasing results from a 2021 sampling assignment, and providing an update on other work under the action plan. …